Experts warn that ‘miracle drugs’ for weight loss can lead to fractures and brittle bones.
The drugs – such as Ozempic or Wegovy – can reduce body weight by 20 percent, but research has shown that they also have a long-term impact on bone density.
Research presented to the American Society for Bone and Mineral Research raised major concerns about the potential side effects of these treatments.
One of the studies – published in the medical journal JAMA – assessed 200 people taking the drugs and found they reduced bone mineral density in the hips and spine compared to a placebo or exercise alone.
This means that patients who use weight loss injections may be at increased risk of the bone-thinning disease osteoporosis.
Experts have warned that weight loss ‘miracle drugs’ such as Ozempic and Wegovy could lead to fractures and brittle bones
Research presented to the American Society for Bone and Mineral Research found that people taking the drugs had reduced bone mineral density in the hips and spine
‘The weight loss benefits are undeniable, but the evidence also shows loss of lean mass and bone density, which is concerning, especially for patients with conditions such as osteoporosis, who are vulnerable to fractures,’ says Dr Taher Mahmud, founder of the University of London. Osteoporosis Clinic.
‘The data is worrying for people who are already at increased risk of osteoporosis or bone fractures, such as people with obesity or type 2 diabetes.’
Ozempic and Wegovy are a type of drug known as a GLP-1 agonist that reduces feelings of hunger.
Last week, the government announced it would offer the drugs to the unemployed.
But experts say giving these injections to thousands could increase cases of osteoporosis, which can lead to dangerous bone fractures and falls.
Dr. Mahmud says it’s critical that patients taking GLP-1 drugs exercise. ‘The importance of strength training and cardiovascular exercise should be promoted to help protect against muscle and bone loss.
“Tackling obesity is something we as a nation need to tackle.
‘But it is essential that we combine medicine with education and support to ensure that those taking GLP-1 agonists know the importance of good nutrition and exercise.’